Delta-Fly Pharma, Inc.JP:4598
| Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 |
---|
Profit (loss) before income taxes | -245 | -671 | -1,552 | -859 | -964 | -1,326 | -1,427 |
---|
Depreciation | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
---|
Interest income | -0 | -0 | -1 | -0 | -0 | -0 | -0 |
---|
Foreign exchange losses (gains) | -1 | 1 | 2 | 3 | -0 | 3 | 1 |
---|
Share issuance costs | 1 | 15 | 1 | 4 | 2 | 4 | 18 |
---|
Increase (decrease) in accounts payable - other | -78 | 8 | 54 | -14 | 4 | 21 | 117 |
---|
Increase (decrease) in deposits received | 1 | 0 | 0 | -0 | 0 | 0 | 1 |
---|
Other, net | -48 | 38 | -42 | 36 | 14 | -4 | 11 |
---|
Subtotal | 127 | -545 | -1,647 | -718 | -943 | -1,300 | -1,277 |
---|
Interest received | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
---|
Income taxes refund (paid) | - | - | - | -9 | 2 | -3 | -3 |
---|
Net cash provided by (used in) operating activities | 100 | -585 | -1,649 | -727 | -940 | -1,303 | -1,280 |
---|
Purchase of property, plant and equipment | - | -2 | -13 | -1 | - | -0 | -1 |
---|
Proceeds from refund of leasehold and guarantee deposits | - | - | - | - | - | - | 1 |
---|
Other, net | - | -2 | - | - | - | -0 | - |
---|
Net cash provided by (used in) investing activities | - | -4 | -13 | -1 | - | -0 | 0 |
---|
Proceeds from issuance of bonds | - | - | - | - | - | 400 | - |
---|
Redemption of bonds | - | - | - | - | - | -400 | - |
---|
Proceeds from stock issuance to a third party | - | - | - | - | - | - | 499 |
---|
Proceeds from issuance of shares resulting from exercise of share acquisition rights | - | - | - | 863 | 120 | 879 | 1,351 |
---|
Proceeds from issuance of share acquisition rights | - | - | - | 6 | - | 4 | 4 |
---|
Purchase of treasury shares | - | - | -0 | - | -0 | -0 | - |
---|
Net cash provided by (used in) financing activities | 293 | 3,317 | 100 | 875 | 120 | 883 | 1,853 |
---|
Effect of exchange rate change on cash and cash equivalents | 1 | -1 | -2 | -3 | 0 | -3 | -1 |
---|
Net increase (decrease) in cash and cash equivalents | 393 | 2,727 | -1,565 | 145 | -820 | -424 | 573 |
---|